| Claire Van Eenwyk, MD | |
|
6013 Farrington Rd, Suite 301, Chapel Hill, NC 27517-8172 | |
| (919) 962-4824 | |
| Not Available |
| Full Name | Claire Van Eenwyk |
|---|---|
| Gender | Female |
| Speciality | Allergy & Immunology |
| Location | 6013 Farrington Rd, Chapel Hill, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174733943 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 2009-00392 (North Carolina) | Primary |
| Entity Name | University Of North Carolina At Chapel Hill |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
The Wall Street Journal: "Although insurers generally oppose the Democrats' health-care bill, an overhaul would give the industry a chance to boost its diminishing rolls with an influx of young customers who tend to be healthy and profitable to cover. The legislation, which Congress will vote on soon, is designed to get millions of young people to buy health insurance, using a mixture of subsidies to make coverage more affordable and penalties for people who remain uninsured."
Despite the fact that certain racial and ethnic minorities get pancreatic cancer more often, are diagnosed at a younger age and die sooner, clinical trials fail to include representative proportions of non-White patients at every phase of study, according to research that was selected for presentation at Digestive Disease Week 2021.
Angiotech Pharmaceuticals, Inc. today announced that, further to its news release issued earlier today, the Company and certain of its subsidiaries have voluntarily commenced proceedings under the Companies' Creditors Arrangement Act in order to continue implementation of its previously announced recapitalization transaction, having obtained an Initial Order from the Supreme Court of British Columbia today.
Biomerix Corporation and Gel Company today announced a strategic distribution agreement for the Biomerix 3D Scaffold, a novel three-dimensional tissue scaffold. Under the agreement, Gel Company will market and distribute the Biomerix 3D Scaffold to researchers in the life science community across the United States.
Genome instability is the main risk factor in the development of tumours in humans. Understanding how, where, when and why these mutations are produced in DNA is one of the great objectives of the global scientific community.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Claire Van Eenwyk, MD 2520 Meridian Pkwy, Suite 200, Durham, NC 27713-4202 Ph: (919) 666-4743 | Claire Van Eenwyk, MD 6013 Farrington Rd, Suite 301, Chapel Hill, NC 27517-8172 Ph: (919) 962-4824 |
News Archive
The Wall Street Journal: "Although insurers generally oppose the Democrats' health-care bill, an overhaul would give the industry a chance to boost its diminishing rolls with an influx of young customers who tend to be healthy and profitable to cover. The legislation, which Congress will vote on soon, is designed to get millions of young people to buy health insurance, using a mixture of subsidies to make coverage more affordable and penalties for people who remain uninsured."
Despite the fact that certain racial and ethnic minorities get pancreatic cancer more often, are diagnosed at a younger age and die sooner, clinical trials fail to include representative proportions of non-White patients at every phase of study, according to research that was selected for presentation at Digestive Disease Week 2021.
Angiotech Pharmaceuticals, Inc. today announced that, further to its news release issued earlier today, the Company and certain of its subsidiaries have voluntarily commenced proceedings under the Companies' Creditors Arrangement Act in order to continue implementation of its previously announced recapitalization transaction, having obtained an Initial Order from the Supreme Court of British Columbia today.
Biomerix Corporation and Gel Company today announced a strategic distribution agreement for the Biomerix 3D Scaffold, a novel three-dimensional tissue scaffold. Under the agreement, Gel Company will market and distribute the Biomerix 3D Scaffold to researchers in the life science community across the United States.
Genome instability is the main risk factor in the development of tumours in humans. Understanding how, where, when and why these mutations are produced in DNA is one of the great objectives of the global scientific community.
› Verified 9 days ago
Juliana B Sullivan, DO Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 101 Cosgrove Ave Ste 110, Chapel Hill, NC 27514 Phone: 919-929-9612 Fax: 919-929-9182 | |
Arvil Wesley Burks, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 4032 Bondurant Hl Cb #7000, Chapel Hill, NC 27599 Phone: 919-966-4161 | |
Dr. Mildred Kwan, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 100 Eastowne Dr Fl 5, Chapel Hill, NC 27514 Phone: 849-947-2645 Fax: 984-974-2660 | |
Scott P Commins, MD, PHD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 100 Eastowne Dr, Chapel Hill, NC 27514 Phone: 984-974-2645 Fax: 984-974-2660 | |
David Jordan Fitzhugh, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 101 Cosgrove Ave, Suite 110, Chapel Hill, NC 27514 Phone: 919-929-9612 |